| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |